Armitstead, Annie; Grether, Lara; Creech, Kealani (Brigham Young University)
Faculty Advisor: Watt, Richard (Brigham Young University, Biochemistry)
Lateral Flow Immunoassays (LFI) are simple tests that detect specific levels of antigens or antibodies in patient samples. Requiring only a few minutes, small sample sizes and no read-out equipment, LFI�s are an invaluable and time efficient testing technique. Made up of multiple layers they facilitate the capillary flow of a sample through protein detection zones and can be developed to detect virtually any disease or condition.
Despite the attractive attributes of these tests, the assembly of an LFI strip requires expensive machines, trained personnel, and materials not easily accessible to low-resourced labs or clinics. Developing an innovative point-of-care platform designed to be streamlined, low-cost, and intelligible to the unskilled would open the door of medicine to even the most underprivileged clinics in the world.
We are currently developing a paper LFI that uses a single sheet of copy paper with the ability to filter whole blood as well as replacing high-priced machines with stencils and pens which can still deliver detection proteins to the designated test zones. This avenue of testing is supported by previous experiments we have done with protein pens and tagged antibodies. Using anti-mouse and anti-hCG antibodies as our control and test lines respectively, we spike our sample with hCG mouse antibodies tagged with nanoparticles, and we are able to see binding of both proteins with their respective antibodies. We have seen results in our new testing technique that is easily comparable with currently commercialized LFI's: visual results of binding within 1 min, successful transformation of printer paper into a functional binding platform, and consistent protein binding at a 1/10^5 concentration. Once this concept can be translated to different inks in order to diagnose a plethora of varying conditions, we'll be able to detect diseases and other important biomarkers no matter the limiting low-resource circumstances.